IL1B and ductal breast carcinoma in situ: In this study, we investigate the role of TIB induced activation of the IL-1β-NFκB signaling axis in TNBC cell lines, and explore the relationship between TIB, IL-1β, and clinical outcomes in hormone receptor negative (HR−) DCIS and invasive breast cancer.